Abstract
If there were no danger of sudden death (SD), ventricular arrhythmias (VA) would have little importance in practice. If we consider SD to be death that presents within an hour of the onset of the first symptoms, there is one SD per minute in the United States [1, 2]. Although in Spain there are no exact statistics on the number of SD, the estimation in that there are more than 30,000 per year. Eighty to ninety per cent of the SD are of cardiac origin and of these 80–90% are due to ventricular fibrillation precipitated by premature ventricular complexes (PVC). For this reason, anything related to PVC treatment is important. No study [3] has demonstrated that empirical administration of an antiarrhythmic drug reduces the risk of SD.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Julian DC: Toward preventing coronary death from ventricular fibrillation. circulation 1976; 54: 360–366.
Wenger NK, Mock MB, Burgkist I: Ambulatory ECG recording. Current Probl Cardiol 1980; 5: 1–42.
Julian DG: Prevention of sudden death. In: Harrison DC (ed) Cardiac arrhythmias. A decade of progress. GK Hall Med Publ, Boston, 1981; 111.
Velebit V, Podrid P, Lown B, Cohen B, Graboys T: Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 1982; 65: 886–894.
Bayes de Luna A, Serra Grima JR, Oca F: ECG de Holter. Ed Científico-Médica, Barcelona, 1983.
Ruberman V, Weinblatt E, Goldberg J, Frank CW, Shapiro S: Ventricular premature beats and mortality after acute myocardial infarction. N Engl J Med 1977; 279: 750–757.
Harrison DC (ed): Cardiac arrhythmias. A decade of progress. GK Hall Med Publ, Boston, 1981.
Graboys TB, Lown B, Podrid PJ, De Silva R: Long term survival of patients with malignant ventricular arrhythmias treated with antiarrhythmic drugs. Am J Cardiol 1982; 50: 437–445.
Myerburg RJ, Kessler K, Kiem I, et al.: Relationship between plasma levels of procainamide suppression of PVC and prevention of recurrent ventricular tachycardia. Circulation 1981; 64: 280–288.
Horowitz LN, Josephson ME, Kastor J A: Intracardiac electrophysiologic studies as a method for the optimation of drug therapy in chronic ventricular arrhythmias. Prog Cardiovasc Dis 1980; 23: 81–89.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
de Luna, A.B. (1988). Introduction. In: de Luna, A.B., Betriu, A., Permanyer, G. (eds) Therapeutics in Cardiology. Developments in Cardiovascular Medicine, vol 81. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1333-2_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-1333-2_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7094-2
Online ISBN: 978-94-009-1333-2
eBook Packages: Springer Book Archive